First-episode schizophrenia Gitlin M, Nuechterlen K, Subotnik KL, et al. 2001. Clinical outcome following neuroleptic discontinuation in patients with remitted recent- onset schizophrenia. Am J Psychiatry, 158:1835–42. Kane JM, Leucht S, Carpenter D, et al. 2003. Expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry, 64(Suppl 12):5–19. Kay S, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale for schizophrenia. Schizophr Bull, 13:261–78. Lieberman JA, Phillips M, Gu H, et al. 2003. Atypical and conventional antipsychotic drugs in treatment – naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology, 28:995–1003. Lieberman JA, Tollefson G, Tohen M, et al. 2003. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first- episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry, 160:1396–404. McEvoy JP, Hogarthy GE, Steingard S. 1991. Optimal dose of neuroleptic in acute schizophrenia: a controlled study of the neuroleptic threshold and higher haloperidol dose. Arch Gen Psychiatry, 48:739–45. Oosthuizen P, Emsley R, Turner JH, et al. 2004. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis. Int J Neuropsychopharmacol, 7:121–31. Peralta V, Cuesta MJ, Marinez-Larrea A, et al. 2000. Differentiating primary from secondary negative symptoms in schizophrenia: a study of neuroleptic-naive patients before and after treatment. Am J Psychiatry, 157:1461–6. Remington G, Kapur S, Zipursky RB. 1998. Pharmacotherapy of first- episode schizophrenia. Br J Psychiatry, 172(Suppl 33):66–70. Sanger TM, Lieberman JA, Tohen M, et al. 1999. Olanzapine versus haloperidol treatment in first-episode psychosis. Am J Psychiatry, 156:79–87. Woods SW. 2003. Chlorpromazine equivalent doses for the newer atypical antipsychcotic. J Clin Psychiatry, 64:663–7. Neuropsychiatric Disease and Treatment 2005:1(2) 185